GE launches molecular imaging business unit

Article

Siemens reaches SPECT/CT milestoneLantheus adds new Mo-99 supply

GE launches molecular imaging business unit

GE has upgraded its commitment to molecular imaging with the unveiling at the SNM meeting of a business unit dedicated to this modality. Previously, molecular imaging had been part of the company's CT unit. Former ultrasound chief Terri Bresenham will lead the new MI business. (The newly appointed vice president of molecular imaging describes the significance and strategy behind GE's new approach in the next issue of DI SCAN.)

Bolstering the corporate move is the Discovery PET/CT 690, a superpremium research-oriented scanner, and other recent additions to company's MI portfolio: the SPECT Discovery NM 530 and SPECT/CT Discovery NM/CT 570c configurations. The gamma cameras in each product include flat-panel detectors made from cadmium/zinc/telluride and dubbed Alcyone.

Siemens reaches SPECT/CT milestone

Demand for SPECT/CT is on the rise, according to Siemens Healthcare, which this week announced the pending 500th installation of its hybrid nuclear medicine technology at the Centre Hospitalier Universitaire de Sherbrooke in Quebec. The facility is scheduled to receive a Symbia T6 (six-slice) SPECT/CT system June 18, an installation the company is framing as demonstrating the "clear market shift toward diagnostic SPECT/CT procedures."

Lantheus adds new Mo-99 supply

Lantheus Medical Imaging has cut a deal to receive molybdenum-99, the generator isotope of technetium, from a nuclear reactor in Australia. The agreement, struck with the Australian Nuclear Science and Technology Organization (ANSTO), positions Lantheus to become the first company to supply technetium-99m derived from low-enriched uranium targets, the source used by ANSTO's new OPAL reactor. The first in what Lantheus expects will be regular shipments of Mo-99 is scheduled to arrive soon for use in the company's TechneLite generator line, which is currently distributed to the U.S. and Canadian markets to produce technetium.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.